is one of prostanoids and it is biosynthesized from arachidonoic acid liberated from membrane phospholipids by phospholipase A 2 . Cyclooxygenase and thromboxane systhase participate in the synthesis of TXA 2 from arachidonoic acid. Although TXA 2 is unstable with a chemical half-life of about 30 s, 1) it plays an important role in platelet aggregation and constriction of vascular and smooth muscle cells.
2) It has been shown that TXA 2 is involved in cardiovascular disorders, including myocardial infarction, angina, atherosclerosis, ischemic heart disease, and pregnancy-induced hypertension. 3) TXA 2 exerts its action through thromboxane A 2 receptor (TP), which is a member of G-protein-coupled receptor (GPCR) superfamily. Although TP is encoded as a single gene, human TP consists of two alternative splicing isoforms termed TPa and TPb.
3) TPa cDNA was cloned from human placenta and megakaryocyte MEG-01 cells, 4) and TPb cDNA was cloned from human umbilical vein endothelial cells (HUVEC). 5) TPa consists of 343 amino acids and TPb consists of 407 amino acids. They share the first 328 amino acids and differ in carboxyl-terminal cytoplasmic region. Recent study demonstrated that many kinds of cells or tissues expressed both TPa and TPb.
It is known that stimulation of TP results in numerous downstream signals. 6) In many cells, TP has been reported to couple to G q , the stimulation of which results in phosphoinositide hydrolysis and elevation of intracellular free Ca 2ϩ concentration. 7, 8) On the other hand, it has also been reported that the stimulation of TP affects a production of cyclic AMP, increase or decrease, suggesting a possible coupling of TP to G s and/or G i . 9, 10) Moreover, it has been shown that TP couples to G 12/13 in platelets, 11, 12) vascular smooth muscles, 13) and glial cells, 14) and that it couples to G h , 15) which is referred to act as a transglutaminase. Because TPa and TPb differ in only their carboxyl-terminal regions, the ligand-binding domain is the same for both TP isoforms. On the other hand, the first, second, third cytoplasmic loops and the carboxylterminal region of TP are assumed to be required for the coupling with G-protein(s). [16] [17] [18] [19] Both TPa and TPb exhibit identical coupling to G q /PLC and they display different regulation of adenylyl cyclases. Although there is a possibility that TP couples to many kinds of G-proteins, it remains unclear whether each TP isoform selectively couples to G-protein(s). Furthermore, it should be solved whether each isoform of TP has own unique signal or not.
It has been reported that the stimulation of TP results in the activation and phosphorylation of ERK1/2. 20, 21) However, it is not fully understood whether each isoform of TP has a different mechanism in activation of ERK1/2. In the present study, we investigated the difference in the mechanisms of TP-mediated ERK1/2 phosphorylation between TPa and TPb using the cells expressing TPa and TPb. Receptor Binding The cells were incubated in the buffer of 10 mM HEPES-10 mM EDTA, pH 7.4 for 15 min on ice. After aspirating the buffer, they were scraped and sonicated (5 s, interval 30 s), and suspended in the buffer. The homogenate was centrifuged at 17400ϫg for 10 min to obtain membranes. The membranes were washed twice with the homogenizing buffer and finally suspended in a small volume of 0.32 M sucrose, 5 mM MgCl 2 , 10 mM HEPES, pH 7.4, and they were stocked at Ϫ80°C until the experiments were performed. Binding of [ 3 H]-SQ29548 was performed as described previously. 22) Membranes (50 mg/tube) were incubated with 20 nM [ 3 H]-SQ29548 (30 Ci/mmol) for 30 min at 30°C, and reactions were stopped by adding of 2 ml of icecold washing buffer (140 mM NaCl, 10 mM Tris-HCl, pH 7.4). The reaction mixture was immediately filtered under reduced pressure through a Whatman GF/B glass fiber filter, and the filter was washed three times with the washing buffer. The amount of radioactivity bound to GF/B glass fiber filter was counted by liquid scintillation counting. Nonspecific binding was defined as the amount of binding in the presence of 10 mM U46619.
MATERIALS AND METHODS

Materials
Phosphoinositide Hydrolysis Phosphoinositide hydrolysis was monitored as previously described.
23) The cells were seeded in 12-well plates at the density of 3ϫ10 with modified Tyrode's solution (10 mM HEPES, pH 7.4, 137 mM NaCl, 2.7 mM KCl, 1.0 mM MgCl 2 , 0.18 mM CaCl 2 , 5.6 mM glucose) and preincubated in the 10 mM LiCl containing Tyrode's solution at 37°C for 10 min. The cells were incubated with indicated concentrations of U46619 for 20 min, and the reaction was terminated by addition of 5% trichloroacetic acid (TCA) after aspiration of the incubated solution. The TCA extract was washed three times with diethyl ether to remove TCA, and remained diethyl ether was removed by maintaining the samples at 47°C. Total [
3 H]-inositol phosphates were separated by anion exchange column (AG1X-8, formate form) as previously descrived 23) and measured their radioactivity. For determining total [ 3 H]-phosphoinositides, the TCA precipitate was dissolved in 1 N NaOH, and the 3 H radioactivity was measured after neutralization.
Western Blotting TPa-SC2 and TPb-SC15 cells were seeded into 12-well plates at the density of 1.0ϫ10 5 cells/well. One day after seeding, the medium was changed to DMEM containing 0.5% FCS, and the cells were cultured for additional 2 d. They were washed twice with modified Tyrode's solution and preincubated for 10 min at 37°C. After the cells were incubated with drugs for various periods, the medium was aspirated. The cells were solubilized by the addition of sample buffer of which composition was 75 mM Tris-HCl, 2% SDS, 10% glycerol, 3% 2-mercaptoethanol, 0.003% bromophenol blue, pH 6.8. The sample was boiled at 95°C for 5 min and resolved by 11% SDS-polyacrylamide gel electrophoresis (PAGE). Proteins were transferred electrically from the gel onto Hybond-P polyvinylidene difluoride membranes (Amersham Biosciences) by the wet blotting method. The immunoblots were blocked for 30 min with 2% skim milk in Tris-buffered saline containing 0.05% Tween 20 (TBST) at 25°C, and incubated with anti-phospho-ERK antibody (rabbit, Cell Signaling Technology, 1000 times dilution) or anti-ERK antibody (rabbit, Cell Signaling Technology, 600 times dilution) for 2 h at 25°C. The immunoblots were washed several times and incubated with a 1 : 3000 dilution of horseradish peroxidase-conjugated goat anti-rabbit IgG (Cell Signaling Technology) in TBST containing 2% BSA for 2 h at 25°C. Blots were developed by using a chemiluminescence assay kit (ECLTM Western Blotting detection reagent, Amersham Biosciences) and visualized by exposing the membrane to Hyper-film ECL (Amersham Biosciences). Intensities of the bands were analyzed by NIH image software.
Adenovirus Infection Adenoviruses encoding the amino-terminal region containing the RGS domain of p115RhoGEF (p115-RGS; amino acids 1-252) were prepared as described previously. 24, 25) Each recombinant adenovirus contain a green fluorescent protein (GFP) gene, allowing direct observation of the infection state. TPa-SC2 and TPb-SC15 cells were seeded into 12-well plates at the density of 1.0ϫ10 5 cells/well. One day after seeding, the medium was changed to DMEM containing 0.5% FCS, and the cells were infected with 100 MOI adenovirus vector coding p115-RGS. The cells were cultured for additional 48 h, and used for the experiments. Under these conditions, almost 100% of cells were infected with adenoviruses coding for GFP, showing green fluorescence.
Data Analysis The data were expressed as meanϮS.E., and the significant difference (pϽ0. U46619-Induced Phosphoinositide Hydrolysis in TPa a-SC2 and TPb b-SC15 Cells U46619 caused phosphoinositide hydrolysis in a concentration-dependent manner in both TPa-SC2 and TPb-SC15 cells. The EC 50 value was approximately 30 nM in both cells, and the maximum response was almost the same (Fig. 1) . In CHO cells without transfection of TP isoform, U46619 did not show any hydrolysis of phosphoinositides (data not shown). These results suggest that the coupling efficiency of TP with G q/11 may be almost the same between TPa-SC2 and TPb-SC15 cells.
U46619-Induced Phosphorylation of ERK1/2 in TPa a-SC2 and TPb b-SC15 Cells It has been shown that the stimulation of TP results in activation of ERK1/2. 26, 27) However, it is unclear whether TP isoforms activate ERK1/2 with distinct mechanisms or not. Then, TP-mediated phosphorylation of ERK1/2 was examined in TPa-SC2 and TPb-SC15 cells (Fig. 2) . U46619 at 1 mM caused the phosphorylation of ERK1/2 in a time-dependent manner. In TPa-SC2 cells, U46619 caused the phosphorylation of ERK1/2 with a peak of 5 min and the phosphorylation was declined gradually until 60 min. On the other hand, in TPb-SC15 cells U46619 caused the phosphorylation of ERK1/2 with a peak of 5-10 min, and the phosphorylation was maintained to a relatively high level until 60 min. Then, we analyzed the ERK1/2 phosphorylation at 5 and 30 min after U46619 treatment in the following analysis. In both TPa-SC2 and TPb-SC15 cells, U46619 caused phosphorylation of ERK1/2 in a concentration-dependent manner (Fig. 3) .
Furthermore, the pretreatment of both cells with SQ29548, a TP antagonist, resulted in the abolishment of U46619-induced ERK1/2 phosphorylation at 5 and 30 min, and PD98059, a MEK inhibitor, potently inhibited U46619-induced ERK1/2 phosphorylation at 5 and 30 min in both TPa-SC2 and TPb-SC15 cells (data not shown), suggesting that U46619-induced phosphorylation of ERK1/2 is mediated by TP and ERK cascade.
Effect of Pertussis Toxin (PTX) on U46619-Induced Phosphorylation of ERK1/2 in TPa a-SC2 and TPb b-SC15
Cells It is suggested that one of trimeric G-proteins to communicate with TP is G i . 28 ) Then, we examined the effect of pertussis toxin (PTX) on U46619-induced phosphorylation of ERK1/2 in TPa-SC2 and TPb-SC15 cells (Fig. 4) . U46619-induced phosphorylation of ERK1/2 at 5 min was clearly inhibited by the pretreatment with PTX in both TPa-SC2 and TPb-SC15 cells, suggesting that G i might be involved in TP-mediated phosphorylation of ERK1/2 in both TPa-SC2 and TPb-SC15 cells. In contrast to 5-min incubation with U46619, the phosphorylation of ERK1/2 at 30-min incubation with U46619 was little affected by the pretreatment with PTX in both TPa-SC2 and TPb-SC15 cells.
Possible Involvement of G 12/13 in U46619-Induced ERK1/2 Phosphorylation in TPa a-SC2 and TPb b-SC15 Cells To clarify the involvement of G 12/13 in TP-mediated ERK1/2 phosphorylation, we used the cells overexpressed with p115-regulator of G-protein signaling (RGS) using an adenovirus vector (Fig. 5) . The RGS domain of p115-RhoGEF (guanine nucleotide exchange factor) associates with Ga 12/13 , and overexpression of this domain causes the decrease in free Ga 12/13 , resulting in an inhibition of G 12/13 -mediated signal transduction. 25, 29) Overexpressed p115-RGS had a tendency to inhibit U46619-induced ERK1/2 phosphorylation at 30 min in TPb-SC15 cells, but not in TPa-SC2 cells. The results suggest that G 12/13 may be involved in TPmediated ERK1/2 phosphorylation in the cells expressing TPb, but not TPa. When the cells were incubated with U46619 for 5 min, overexpression of p115-RGS little affected to TP-mediated ERK1/2 phosphorylation in both TPa-SC2 and TPb-SC15 cells.
Effect of H89 on U46619-Induced ERK1/2 Phosphorylation in TPa a-SC2 and TPb b-SC15 Cells Since TPa and TPb have been shown to induce different cyclic AMP responses, 9, 10) we examined the effect of H89, a PKA inhibitor, on TP-mediated ERK1/2 phosphorylation in both TPa-SC2
and TPb-SC15 cells (Fig. 6) . While H89 did not affect TPmediated ERK1/2 phosphorylation in TPb-SC15 cells, it potently inhibited TP-mediated ERK1/2 phosphorylation in TPa-SC2 cells.
DISCUSSION
In the present study, we examined the TP isoform-selective pathway to activate ERK1/2 using the cells stably expressing TPa and TPb, TPa-SC2 and TPb-SC15 cells. TPa-SC2 and TPb-SC15 cells demonstrated the similar level of [ almost the same, showing that TPa and TPb had almost the same coupling efficiency to G q/11 . The similar result was reported in HEK293 cells stably expressing TPa and TPb with G 11 or G 16 that U46619 induced an elevation of intracellular Ca 2ϩ concentration and a production of inositol phosphates to a similar extent in both TP isoforms. 10) In contrast to phosphoinositide hydrolysis, U46619 caused ERK1/2 phosphorylation through the distinct signaling pathways between TPa and TPb. Although TPa-SC2 cells showed a transient phosphorylation of ERK1/2, TPb-SC15 cells showed the sustained phosphorylation. The ability of nerve growth factor to induce sustained activation of the ERK has been implicated in PC12 cell differentiation and many reports indicate the relationship between sustained ERK activation and differentiation. 30, 31) Although the role of sustained ERK1/2 activation remains to be solved in nonneuronal cells, TPa and TPb may have distinct signal pathways to induce proliferation or differentiation.
The ERK1/2 phosphorylation at early stage (5 min) was inhibited by PTX in both TPa-SC2 cells and TPb-SC15 cells. However, the ERK1/2 phosphorylation observed at late stage (30 min) in TPb-SC15 cells was not inhibited by PTX. These results indicate the involvement of G i in ERK1/2 phosphorylation at early stage is common between TPa and TPb. Phosphorylation of ERK1/2 through G i is thought to be mediated via Gbg subunits released from the activated G i . 32) It has been reported that the released Gbg subunits caused the phosphorylation of ERK1/2 through the activation of Src and small G-protein Ras. 33, 34) The inovolvement of G i in phosphorylation of ERK1/2 was reported in the case of other GPCRs, such as dopamine D 2 receptor 35) and erythropoietin receptor. 36) In the case of TP, however, there are distinct reports about the involvement of G i in the phosphorylation of ERK1/2. Although it was shown that G i participated in TPmediated ERK1/2 phosphorylation in human bladder cancer cells, 37) Miggin and Kinsella 26) reported that G i did not participate in TP-mediated ERK1/2 phosphorylation in human uterine smooth muscle cells. In HEK293 cells stably expressing TPa or TPb, TP caused ERK1/2 phosphorylation in a G i -independent manner. 38) These opposite reports suggest that there are complicated signaling pathways to activate ERK1/2, and the expression levels of downstream signaling molecules of TP may be different between the cells.
TP is a representative G q -coupled receptor, 7) and it has also been reported to couple to G 12/13 family. 11, 12) Then, we investigated the involvement of G 12/13 in TP-mediated ERK1/2 phosphorylation in TPa-SC2 and TPb-SC15 cells. TPb-SC15 cells had a tendency to reduce U46619-induced phosphorylation of ERK1/2 at late stage (30 min) after the infection of p115-RGS. It is suggested that only TPb mediates a signal to ERK1/2 phosphorylation through G 12/13 even if involvement of pathway through G 12/13 is not a major determinants to activate ERK1/2.
The phosphorylation of ERK1/2 was inhibited by H89, an inhibitor of protein kinase A (PKA), in TPa-SC2 cells, but not in TPb-SC15 cells. Previous study suggested that elevated cyclic AMP level activates the ERK1/2 in a certain cells. 39) These results are supported by the observation that the stimulation of TP causes cyclic AMP production in HEK293 or CHO cells expressing TPa but not TPb. 9, 10) It has been also shown that H89 abrogates the phosphorylation of ERK1/2 in both HEK293 cells stably expressing TPa or TPb. 38) Thus, it is assumed that different cells express different level of signaling molecules downstream of TP, and the activation pathways of ERK1/2 are largely complicated. It has been shown that H89 inhibits other kinases than PKA, including protein kinase C (PKC). 40) But GF109203X, a PKC inhibitor, prevented the phosphorylation of ERK1/2 to a similar extent between TPa-SC2 cells and TPb-SC15 cells (Miyosawa et al., unpublished observation), suggesting an involvement of PKC in the activation of ERK1/2 is common between TPa and TPb, and that isoform-specific sensitivity to H89 is not derived from a sensitivity to PKC. To clarify an involvement of PKA in the phosphorylation of ERK1/2, further study will be necessary to use forskolin or dibutyryl cyclic AMP that activates PKA. Although we could not rule out a possible involvement of other kinases, the results indicate the difference in H89-sensitivity and/or distinct signaling pathways between TPa and TPb.
Recently, it has been reported that a transactivation of growth factor receptor participates in GPCR-mediated ERK1/2 phosphorylation, such as muscarinic M 1 receptor, 41) P2Y 2 receptor, 42) and angiotensin II receptor. 43) Stimulations of these receptors result in activation of matrix metalloproteinases followed by proteolysis of growth factor receptor ligand, and the ligand activates its acceptable receptor. 44) It has been shown that the stimulation of TP causes a transactivation of epidermal growth factor (EGF) receptor. 37, 45) In the present study, we could not clarify the major mechanism involved in TP-mediated activation of ERK1/2 at late stage. It is assumed that the transactivation may participate in TP-mediated ERK1/2 phosphorylation at late stage, likely the report that the stimulation of TP causes the phosphorylation of EGF receptor with a peak of 30 min in ECV304 cells expressing both TP isoforms. 37) The present study demonstrates that both TPa and TPb couple to G q/11 with the same coupling efficiency. In addition, both TPa and TPb mediate the phosphorylation of ERK1/2, and G i may be involved in TP-mediated ERK1/2 phosphorylation in both isoforms. Furthermore, H89-sensitive kinase is contributed to TPa-mediated ERK1/2 phosphorylation, while G 12/13 may be contributed to TPb-mediated one.
